EODData

FRA, 1JK: APELLIS PHARMACT.DL-0001

22 Dec 2025
LAST:

20.51

CHANGE:
 0.39
OPEN:
20.51
HIGH:
20.51
ASK:
0.00
VOLUME:
170
CHG(%):
1.91
PREV:
20.13
LOW:
20.51
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
22 Dec 2520.5120.5120.5120.51170
19 Dec 2520.1320.1320.1320.13170
18 Dec 2520.6820.6820.6820.68170
17 Dec 2520.9120.9120.9120.91170
16 Dec 2520.1420.1420.1420.14170
15 Dec 2520.8620.8620.8620.86170
12 Dec 2520.6220.6220.6220.62170
10 Dec 2519.7519.7519.4319.43170
09 Dec 2519.7421.2419.7421.2420
08 Dec 2519.5819.5819.5819.58100

PROFILE

Name:APELLIS PHARMACT.DL-0001
About:Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. It offers EMPAVELI for the treatment of paroxysmal nocturnal hemoglobinuria; and SYFOVRE for treating geographic atrophy secondary to age-related macular degeneration and geographic atrophy (GA). The company also develops EMPAVELI to treat C3 glomerulopathy and immune complex membranoproliferative glomerulonephritis, hematopoietic stem cell transplantation-associated thrombotic microangiopathy, focal segmental glomerulosclerosis, and delayed graft function; and APL-3007, a small interfering RNA, or siRNA for the treatment of GA. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) for development and commercialization of pegcetacoplan; and a collaboration with Beam Therapeutics Inc. focused on the use of Beam's base editing technology to discover new treatments for complement-driven diseases. The company was incorporated in 2009 and is based in Waltham, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:100 Fifth Avenue, Waltham, MA, United States, 02451
Website:https://apellis.com
ISIN:US03753U1060
LEI:254900HS0ZFRXXSB9D42

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:55.25 
Forward P/E:-2.85 
PEG Ratio:5.52 
Price to Sales:2.13 
Price to Book:5.40 
Profit Margin:0.04 
Operating Margin:0.49 
Return on Assets:0.05 
Return on Equity:0.14 
Revenue:882.13M 
EBITDA:71.24M 
Shares:126.29M 
Market Cap:2.59B 

TECHNICAL INDICATORS

MA5:20.470.2%
MA10:20.410.5%
MA20:18.858.8%
MA50:19.564.9%
MA100:20.072.2%
MA200:18.689.8%
STO9:59.92
STO14:82.59 
RSI14:63.61 
WPR14:-17.41 
MTM14:2.97
ROC14:0.17 
ATR:0.76 
Week High:20.912.0%
Week Low:20.131.9%
Month High:21.243.5%
Month Low:16.359.8%
Year High:32.9060.4%
Year Low:13.9047.6%
Volatility:4.49